The emerging therapy of the medication represents a significant development in the care of type 2 diabetes. Different to existing therapies, tirzepatide impacts two pathways – glucagon-like peptide-1 (GLP-1) and the https://tirzepatide-peptide933776.uzblog.net/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment-55680008